Stock DNTH DIANTHUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Dianthus Therapeutics, Inc.

Equities

DNTH

US2528281080

Real-time Estimate Cboe BZX
Other stock markets
 12:50:56 2024-06-17 pm EDT 		5-day change 1st Jan Change
25.01 USD -3.81% Intraday chart for Dianthus Therapeutics, Inc. +29.16% +150.00%
Jun. 12 Dianthus Therapeutics Secures US FDA Approval to Launch Phase 2 Study of DNTH103 in Multifocal Motor Neuropathy MT
Jun. 12 Dianthus Therapeutics Gets FDA Clearance for DNTH103 Phase 2 Trial DJ

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
DIANTHUS THERAPEUTICS, INC.
Bio Therapeutic Drugs
-3.56%+29.16%+150.00% - - 763M - - -
  1. Stock Market
  2. Equities
  3. DNTH Stock
  4. Charts Dianthus Therapeutics, Inc.
  5. Relative Strength Chart